Skip to main content

Table 1 Baseline characteristics

From: Prone positioning in severe ARDS requiring extracorporeal membrane oxygenation

 

All (n = 158)

Prone (n = 38)

Supine (n = 120)

p value

Demographics

 Age (years)

54.5 (41.8–64.0)

51.5 (38.5–64.0)

55.5 (44.0–64.0)

0.549

 Sex (male)

106 (67.1%)

28 (73.7%)

78 (65.0%)

0.321

 BMI (kg/m2)

24.7 (22.9–28.8)

24.8 (24.0–28.7)

24.4 (22.9–28.9)

0.566

 Underlying pulmonary disease

55 (34.8%)

12 (31.6%)

43 (35.8%)

0.631

  COPD

11 (7.0%)

1 (2.6%)

10 (8.3%)

0.229

  Asthma

10 (6.3%)

1 (2.6%)

9 (7.5%)

0.283

  Lung fibrosis

18 (11.4%)

5 (13.2%)

13 (10.8%)

0.694

  Cystic fibrosis

7 (4.4%)

2 (5.3%)

5 (4.2%)

0.775

  LTOT

11 (7.0%)

1 (2.6%)

10 (8.3%)

0.229

  Pulmonary hypertension

6 (3.8%)

0 (0.0%)

6 (5.0%)

0.160

 Comorbidities

  Nicotine abuse

47 (29.7%)

9 (23.7%)

38 (31.7%)

0.348

  Hypertension

49 (31.0%)

10 (26.3%)

39 (32.5%)

0.473

  Diabetes mellitus

24 (15.2%)

6 (15.8%)

18 (15.0%)

0.906

  CAD

20 (12.7%)

5 (13.2%)

15 (12.5%)

0.915

  Chronic renal failure

12 (7.6%)

6 (15.8%)

6 (5.0%)

0.029

  Chronic haemodialysis

2 (1.3%)

1 (2.6%)

1 (0.8%)

0.388

  Liver cirrhosis/hepatitis

17 (10.8%)

3 (7.9%)

14 (11.7%)

0.513

  Immunosuppression

57 (36.1%)

13 (34.2%)

44 (36.7%)

0.783

Procedural characteristics

 Oxygenation pre-ECMO

  FiO2 (%)

100 (80–100)

90 (80–100)

100 (80–100)

0.233

  Horowitz index (mmHg)

77.1 (63.1–107.1)

77.6 (60.1–105.2)

76.8 (63.2–109.0)

0.828

  D(A-a)O2 (mmHg)

531 (419–592)

492 (416–579)

542 (418–595)

0.369

 Duration of MV before ECMO (days)

1.3 (0.3–5.0)

2.2 (0.2–7.6)

1.1 (0.3–3.5)

0.133

 Prone positioning before ECMO

26 (16.5%)

7 (18.4%)

19 (15.8%)

0.708

 Acute renal failure

50 (31.6%)

13 (34.2%)

37 (30.8%)

0.696

 Scores

  SOFA score

14.0 (11.0–16.0)

13.0 (11.0–15.0)

14.0 (11.0–16.8)

0.146

  APACHE II score

26.0 (21.8–32.0)

24.0 (22.8–28.3)

27.0 (20.3–32.0)

0.364

  RESP score

1 (− 2.0–2.0)

0 (− 3.0–2.0)

1.0 (− 2.0–2.0)

0.702

 Causes of ARDS

  Pneumonia

116 (73.4%)

33 (86.8%)

83 (69.2%)

0.032

  Aspiration

15 (9.5%)

2 (5.3%)

13 (10.8%)

0.307

  Inhalation injury

1 (0.6%)

0 (0.0%)

1 (0.8%)

0.572

  Drowning

2 (1.3%)

0 (0.0%)

2 (1.7%)

0.423

  Autoimmune injury

10 (6.3%)

2 (5.3%)

8 (6.7%)

0.757

  Sepsis

10 (6.3%)

1 (2.6%)

9 (7.5%)

0.283

  Pancreatitis

1 (0.6%)

0 (0.0%)

1 (0.8%)

0.572

  Other injuries

3 (1.9%)

0 (0.0%)

3 (2.5%)

0.325

 Pulmonary pathogen spectrum

  Bacterial

62 (39.2%)

16 (42.1%)

46 (38.3%)

0.678

  Viral

30 (19.0%)

13 (34.2%)

17 (14.2%)

0.006

  Fungal

27 (17.1%)

14 (36.8%)

13 (10.8%)

< 0.001

Pneumocystis jirovecii

11 (7.0%)

7 (18.4%)

4 (3.3%)

0.001

  1. APACHE II Acute Physiology and Chronic Health Evaluation, ARDS acute respiratory distress syndrome, BMI body mass index, COPD chronic obstructive pulmonary disease, CAD coronary artery disease, D(A-a)O2 alveolar-arterial gradient of oxygen concentration, ECMO extracorporeal membrane oxygenation, FiO2 fraction of inspired oxygen, LTOT long-term oxygen therapy, MV mechanical ventilation, RESP Respiratory Extracorporeal Membrane Oxygenation Survival Prediction, SOFA Sequential Organ Failure Assessment. Categorical variables are presented as frequency (percentages). Continuous variables are presented as median (IQR)